Company intelligence / Profile preview

MamanPaz

Ownership: Private
Development stage: Commercial

Overview

Maman Biomedical develops proprietary controlled-release gels and patches designed to replace multiple daily injections required during fertility treatments, aiming to improve patient experience by reducing pain, trauma, and lifestyle disruption. No clinical results have been published as of now.

Therapeutic areas: Women's Health
Modalities: Controlled-release therapeutic gelControlled-release therapeutic patchDrug delivery device
Industry: Biotech

Beyond the preview

Go deeper on MamanPaz.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MamanPaz.

Explore the full profile